Medical News

RSS

Health impacts of inhalable constituents of thirdhand smoke

Ever walked into a hotel room and smelled old cigarette smoke? While the last smoker may have left the room hours or even days ago, the lingering odors—resulting from noxious residue that clings to walls, carpets, furniture, or dust particles—are thanks to thirdhand smoke.

4 Nov 2014

NSAIDs protect against colorectal cancer by inducing cell suicide pathways in intestinal stem cells

Aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) protect against the development of colorectal cancer by inducing cell suicide pathways in intestinal stem cells that carry a certain mutated and dysfunctional gene, according to a new study led by researchers at the University of Pittsburgh Cancer Institute and the School of Medicine.

4 Nov 2014

Precision awarded $28 million contract to provide management of disease-study specimens for NIAID

Precision for Medicine announced today that its subsidiary, Precision Bioservices, Inc., has been awarded a 7-year contract of up to $28 million to provide management and oversight of disease-study specimens for the National Institute of Allergy and Infectious Diseases.

4 Nov 2014

Ruthigen enrolls first patient in Phase 1/2 clinical trial of RUT58-60

Ruthigen, Inc., announced today enrollment of the first patient in a Randomized, Double-Blind Phase 1/2 clinical trial to evaluate the safety, tolerability, and potential efficacy of its lead drug candidate, RUT58-60, for use as an adjunct to systemic antibiotics in abdominal surgery.

4 Nov 2014

MO BIO Laboratories announces launch of PowerMag Blood DNA/RNA Isolation Kit

MO BIO Laboratories, Inc., the leader in soil, stool and microbial nucleic acid purification, announces the launch of the PowerMag Blood DNA/RNA Isolation Kit. The kit is designed for automated, hands-free purification of nucleic acids from blood samples using the Thermo Scientific KingFisher automated processing system and other similar automation platforms.

4 Nov 2014

Rigel Pharmaceuticals reports net loss of $20.9 million for third quarter of 2014

Rigel Pharmaceuticals, Inc. today reported financial results for the third quarter and nine months ended September 30, 2014.

4 Nov 2014

Sigma-Aldrich acquires Cell Marque

Sigma-Aldrich Corporation, a leading Life Science and High Technology company, announced it has completed its acquisition of Rocklin, California based Cell Marque Corporation, an industry-leading provider of in vitro diagnostic (IVD) antibody reagents and kits. The Company expects this acquisition to be neutral to mildly accretive to earnings per share in 2015. Terms of the transaction were not disclosed.

4 Nov 2014

Smokers are three times more likely to develop chronic back pain than nonsmokers, study finds

If you want to avoid chronic back pain, put out the cigarette. A new Northwestern Medicine study has found that smokers are three times more likely than nonsmokers to develop chronic back pain, and dropping the habit may cut your chances of developing this often debilitating condition.

4 Nov 2014

Texas A&M AgriLife Extension Service receives grant to help reduce chronic diseases

The Texas A&M AgriLife Extension Service has been awarded a "Programs to Reduce Obesity in High-Obesity Areas" grant to support national efforts by the U.S. Department of Health and Human Services to reduce chronic diseases, promote healthier lifestyles, reduce health disparities and control health care spending.

4 Nov 2014

Douglas Mental Health University Institute researcher wins 2014 Wilder-Penfield prize

The Douglas Mental Health University Institute is proud to announce that its researcher and neurobiologist, Michael Meaney, C.M., Ph.D., C.Q., FRSC, is the 2014 laureate of the prestigious prix Wilder-Penfield.

4 Nov 2014

Inventiva’s IVA337 receives EMA COMP positive opinion on orphan drug designation for SSc treatment

Inventiva, a drug discovery company that focuses on therapeutic approaches involving transcription factors and epigenetic targets, today announces that the Committee for Orphan Medicinal Products (COMP) at the European Medicines Agency (EMA) has given a positive opinion on the designation of IVA337 as an orphan medicinal product.

4 Nov 2014

AbbVie and Myriad Genetics expand Tumor BRACAnalysis CDx collaboration

Myriad Genetics, Inc. announced today that it has signed an expanded companion diagnostic agreement with AbbVie, Inc., a leading global biopharmaceutical company to use Tumor BRACAnalysis CDx™ as a companion diagnostic in support of AbbVie’s novel poly (ADP-ribose) polymerase or PARP inhibitor, veliparib.

4 Nov 2014

CVS Health's net revenues increase 9.7% to $35.0B in third quarter 2014

CVS Health Corporation today announced operating results for the three months ended September 30, 2014.

4 Nov 2014

Astellas, Dana-Farber to develop K-Ras inhibitors for treatment of lung, pancreatic cancers

Dana-Farber Cancer Institute (Dana-Farber) and Astellas Pharma Inc. today announced a three-year collaboration to research and develop small molecule inhibitors of oncogenic K-Ras for the treatment of cancer, including lung cancer.

4 Nov 2014

MSD announces Phase 2b results of doravirine therapy in untreated patients with HIV-1 infection

Merck Sharp & Dohme Ltd. MSD (known as Merck & Co., Inc. in the United States and Canada), today announced the presentation of results from a Phase 2b clinical trial evaluating the safety and efficacy of once daily oral doravirine, an investigational next-generation non-nucleoside reverse transcriptase inhibitor (NNRTI), plus tenofovir/emtricitabine (TDF/FTC) compared to efavirenz plus TDF/FTC in previously untreated patients with HIV-1 infection.

4 Nov 2014

Hospice of the Western Reserve honors more than 2,000 veterans in 2014

Americans across the country will observe Veterans Day on November 11, a special day to salute the men and women who have bravely served our country.

4 Nov 2014

3D brain-like tissue: an interview with Professor David Kaplan, Tufts University

In 2D, neurons tend to form limited connectivity reflective of the 3D complexity in the brain and have more limited cultivation time before reduction in functions.

4 Nov 2014

EBioMedicine: Open access journal from Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. Two of its leading brands, Cell Press and The Lancet, have now joined forces to launch a new open access journal, EBioMedicine.

4 Nov 2014

Bio-Techne to acquire CyVek for $60M

Bio-Techne Corporation announced today that it has agreed to acquire CyVek, Inc. (CyVek) for $60 million in cash, plus a potential earn-out payment of up to $35 million based on CyVek revenue over the 30-month period following the closing and an additional potential earn-out payment based on CyVek revenue through 2020 in excess of $100 million.

4 Nov 2014

Seno Imagio breast imaging system and associated predictive model can help eliminate breast biopsies

Seno Medical Instruments, Inc., the company pioneering the development of opto-acoustic technology as a new tool to improve the process of diagnosing breast cancer, announced that the use of the Seno Imagio breast imaging system and the associated predictive model appear to have the potential to significantly improve the physicians’ ability to accurately rule out breast cancer compared to traditional ultrasound alone.

4 Nov 2014

Medical News

Health impacts of inhalable constituents of thirdhand smoke

NSAIDs protect against colorectal cancer by inducing cell suicide pathways in intestinal stem cells

Precision awarded $28 million contract to provide management of disease-study specimens for NIAID

Ruthigen enrolls first patient in Phase 1/2 clinical trial of RUT58-60

MO BIO Laboratories announces launch of PowerMag Blood DNA/RNA Isolation Kit

Rigel Pharmaceuticals reports net loss of $20.9 million for third quarter of 2014

Sigma-Aldrich acquires Cell Marque

Smokers are three times more likely to develop chronic back pain than nonsmokers, study finds

Texas A&M AgriLife Extension Service receives grant to help reduce chronic diseases

Douglas Mental Health University Institute researcher wins 2014 Wilder-Penfield prize

Inventiva’s IVA337 receives EMA COMP positive opinion on orphan drug designation for SSc treatment

AbbVie and Myriad Genetics expand Tumor BRACAnalysis CDx collaboration

CVS Health's net revenues increase 9.7% to $35.0B in third quarter 2014

Astellas, Dana-Farber to develop K-Ras inhibitors for treatment of lung, pancreatic cancers

MSD announces Phase 2b results of doravirine therapy in untreated patients with HIV-1 infection

Hospice of the Western Reserve honors more than 2,000 veterans in 2014

3D brain-like tissue: an interview with Professor David Kaplan, Tufts University

EBioMedicine: Open access journal from Elsevier

Bio-Techne to acquire CyVek for $60M

Seno Imagio breast imaging system and associated predictive model can help eliminate breast biopsies

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Membrane proteins in focus: Turning high-risk targets into routine workflows

Latest News